Bloomberg Technology

IonQ, Heven AeroTech Partner on Quantum-Enabled Drones

IonQ is expanding its efforts in the national security space, partnering with Heven AeroTech to develop quantum-enabled drones. IonQ CEO Niccolo de Masi joins Caroline Hyde on “Bloomberg Tech.” ——– Like this video? Subscribe to Bloomberg Technology on YouTube:   Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:…

Published

on

IonQ is expanding its efforts in the national security space, partnering with Heven AeroTech to develop quantum-enabled drones. IonQ CEO Niccolo de Masi joins Caroline Hyde on “Bloomberg Tech.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

25 Comments

  1. @MarcellaCasabianca

    November 24, 2025 at 7:57 pm

    Corvix token has a real shot at becoming a household name in DeFi. 🌟

  2. @TeodoroPak

    November 24, 2025 at 7:57 pm

    People will look back at Corvix presale as an obvious buy.

  3. @BeatriceBrogan-z8s

    November 24, 2025 at 7:57 pm

    I think Corvix CRV could set new standards in AI-driven token ecosystems.

  4. @CahuichGillman

    November 24, 2025 at 7:57 pm

    Long-term thinkers will understand the vision behind Corvix CRV.

  5. @BodyWright-n6g

    November 24, 2025 at 7:57 pm

    The attention around Corvix feels like the calm before the storm.

  6. @VirginiaLemons

    November 24, 2025 at 7:57 pm

    The use case of CRV Corvix goes beyond trading — it’s about smarter decentralized tools.

  7. @FidelLima-z6r

    November 24, 2025 at 7:57 pm

    The Corvix CRV presale phase is moving faster than anticipated.

  8. @RichardCaffaratti-y5z

    November 24, 2025 at 7:57 pm

    Corvix could be the next one to catch the wave of mass attention.

  9. @CamAttanasova

    November 24, 2025 at 7:57 pm

    Corvix token shows real use case depth — not just buzzwords.

  10. @ClarkHolguin-b4v

    November 24, 2025 at 7:58 pm

    Corvix CRV feels early but promising.

  11. @AllAshworth

    November 24, 2025 at 7:58 pm

    Corvix token still has plenty of room to grow. 🚀

  12. @MrsStahl-u5l

    November 24, 2025 at 7:58 pm

    Corvix presale continues to attract early adopters.

  13. @BoqueanoOwens

    November 24, 2025 at 7:58 pm

    Corvix presale might end sooner than expected.

  14. @BeverlyPeak

    November 24, 2025 at 7:58 pm

    Corvix CRV presale phase won’t last forever.

  15. @IwonaHuskey

    November 24, 2025 at 7:58 pm

    This isn’t just another hype project — CRV Corvix is building real AI integration.

  16. @AishaDehart

    November 24, 2025 at 7:58 pm

    The market structure forming around Corvix CRV reminds me of early breakout patterns.

  17. @LarryLudwig-q6z

    November 24, 2025 at 7:58 pm

    Corvix token could be one of the first AI projects to really deliver consistent utility.

  18. @RahmUrena

    November 24, 2025 at 7:58 pm

    This market environment is perfect for CRV Corvix to thrive.

  19. @BillieMaria

    November 24, 2025 at 7:58 pm

    Once the full rollout begins, Corvix CRV could take off rapidly.

  20. @SkaroBarlow

    November 24, 2025 at 7:59 pm

    Corvix CRV is gaining recognition fast.

  21. @WernerSchaefer-y7w

    November 24, 2025 at 7:59 pm

    The early excitement around Corvix is justified by its execution so far.

  22. @PorterBegay

    November 24, 2025 at 7:59 pm

    With strong fundamentals like Corvix, patience can pay off massively.

  23. @WallkKline

    November 24, 2025 at 7:59 pm

    AI narratives are heating up again, and Corvix is perfectly positioned.

  24. @RalphVan-f5d

    November 24, 2025 at 7:59 pm

    I think CRV Corvix has the potential to outperform most current midcaps.

  25. @DoctorGuru90

    November 24, 2025 at 8:22 pm

    This guy is so going to jail (once crime is made illegal again)

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version